Company & Sponsor Intelligence

Tetra Discovery Partners

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting1

Completed2

Countries1

Therapeutic footprint

autismneurodevelopmental_other

Indexed studies

NCT05358886A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome
neurodevelopmental_other · United StatesPHASE3

NCT05367960An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
neurodevelopmental_other · United StatesPHASE3

NCT03569631A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
autism · United StatesPHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →